A summit focused on Glucose Transporter 1 deficiency and its impacts.
Official title: The 11th international Glut1 deficiency summit
Funded at Weill Medical Coll of Cornell Univ · NIH-10999935 · Data updated 2026-11-12
This study is bringing together scientists, patients, and advocates to share ideas and improve understanding of Glucose Transporter 1 deficiency (G1D), a condition that can cause epilepsy and learning challenges, with the goal of finding better treatments and support for those affected.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | June 26, 2024 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $5,000 |
| NIH project number | 1R13NS139569-01 |
| Project ID | NIH-10999935 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Glucose Transporter 1 deficiency or those experiencing related symptoms such as epilepsy or intellectual disabilities.
✕Less likely to help
Patients with conditions unrelated to Glucose Transporter 1 deficiency may not receive any benefit from this research.
What this research studies
This research brings together scientists, patients, and advocates to discuss Glucose Transporter 1 deficiency (G1D), a condition linked to epilepsy and intellectual disabilities. The summit aims to share knowledge and foster collaboration among experts to enhance understanding and treatment options for G1D. By harmonizing the voices of the scientific community and patient organizations, the initiative seeks to propel advancements in research and patient care. The event will also highlight recent findings and potential therapeutic approaches, including dietary treatments.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and potential treatment options for patients with Glucose Transporter 1 deficiency.
How similar studies have gone: Previous research efforts in the field have shown promise, indicating that collaborative approaches can yield significant advancements in understanding and treating G1D.
Where this research is happening
-
Weill Medical Coll of Cornell Univ
New York, United States Active
Researchers
- Principal investigator: Pascual, Juan M. — Weill Medical Coll of Cornell Univ
- Study coordinator: Pascual, Juan M.
Related research
Other NIH-funded projects on the same topics.
-
Destruction of noncoding RNAs in cancer
This grant funds research to understand how noncoding RNAs are broken down, which could reveal new ways to influence cancer development and progression.
-
Coaching and Navigation by Community Health Workers via Telehealth for High-Risk Hypertension
A program using telehealth and community health workers to help adults with severe hypertension connect to primary care and follow practical, heart-healthy lifestyle tips.
-
Corticospinal neurons and recovery of precise forelimb movement after spinal cord injury
This project studies how spine injuries change brain circuits and whether targeted rehabilitation helps restore precise forelimb movement.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
ROMA:Women — comparing single vs multiple arterial grafts in women undergoing CABG
A women-focused clinical trial tests whether using more arterial grafts during heart bypass surgery improves outcomes and quality of life for women.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.